Further categorization of these burst keywords facilitated the demarcation of 2 primary thematic areas: (1) cancers induced by KRAS mutations and (2) approaches to cancer treatment, with a predominance of immunotherapy-related terms. This evidence concerns the gene KRAS and cancer.